Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Myeloproliferative Disorders 7Hematologic Neoplasms 5Primary Myelofibrosis 4Thrombocythemia, Essential 1Solid Tumor 1Polycythemia Vera 1Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Leukemia, Neutrophilic, Chronic 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia 1Blast Crisis 1

Interventions

fludarabine phosphate 18Cyclophosphamide 18Busulfan 17Peripheral Blood Stem Cell Transplantation 16Tacrolimus 14Methotrexate 14Antilymphocyte Serum 13Mycophenolic Acid 12Cyclosporine 11Flow Cytometry 9Whole-Body Irradiation 8Filgrastim 7Radiotherapy 6Methylprednisolone 6Melphalan 6Etoposide 6Cord Blood Stem Cell Transplantation 6Therapeutics 5Psychiatric Rehabilitation 5Polymerase Chain Reaction 5thymoglobulin 4Immunoenzyme Techniques 4Sirolimus 3Rituximab 3Ondansetron 3Immunologic Techniques 3Early Intervention, Educational 3Cytarabine 3Aprepitant 3Alemtuzumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Neutrophilic, Chronic × fedratinib × Clear all
NCT05177211 2026-04-17

Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Active not recruiting
25 enrolled 13 charts
MyeloidOther hematologic neoplasm

Myeloproliferative Disorders, Leukemia, Neutrophilic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡